Federal Bank Q3 Profit: Federal Bank on January 16, 2026 reported a 9 percent year-on-year rise in net profit at Rs 1,041 crore for Q3FY26 as against a net profit of Rs 955 crore in the year-ago period, driven by healthy loan growth and stable margins. Consequently, the Kerala-based lender’s shares rose 10% to hit a record high of Rs 271.5 apiece.
Stock Recommendations
At Gold Silver Reports, we provide trusted stock recommendations with clear buy/sell calls, investment strategies, and market insights. Our expert analysis helps traders and investors choose the right stocks, manage risk, and achieve consistent profits in the stock market.
HFCL Share Price Valuation Raises Red Flag: Is the Stock Price at Risk Amid Telecom Challenges?
HFCL Share Price Valuation Raises Red Flag: HFCL Ltd’s latest valuation trends are sending a clear warning to investors. The stock price has moved up sharply in recent months, but current valuations suggest that the risk of a price correction is increasing.
Nike Struggles Continue, Turnaround Plan Shows Early Success
Nike Struggles: Nike’s efforts to reinvigorate its business are showing some results despite continued challenges in China and with its ailing Converse brand.
Hindustan Zinc Share Price Target Rs 660: Why Jefferies Is Bullish on the Stock
Shares of Hindustan Zinc have been gaining attention again after global brokerage firm Jefferies initiated coverage on the stock with a Buy rating and a target price of Rs 660. The brokerage believes the company is well placed to benefit from rising silver and zinc prices and expects strong earnings growth over the next few years.
Hindustan Zinc Share Price Jumps 2.65%: Investors Cheer Strong Buying Mood
Hindustan Zinc Ltd (HZL) has added 11.3% over last one month compared to 2.15% fall in BSE Metal index and 0.69% rise in the SENSEX
Wockhardt Share Jumps 19% on Heavy Buying — Why the Pharma Stock is Rising Today
Wockhardt shares moved higher by 19 per cent, to ₹1,472.70 on the National Stock Exchange (NSE) in Monday’s intraday trade, amid heavy volumes after the company said the United States Food and Drug Administration (USFDA) has formally accepted the New Drug Application (NDA) for its first-in-class antibiotic ‘Zaynich’.
Ashok Leyland share jumps to 52-week high on merger update, should you buy?
Ashok Leyland share price hit a fresh 52-week high after a major merger update, boosting investor sentiment. Check latest share move, key merger details, expert view and what it means for traders and long-term investors.